Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Common Equity (2016 - 2025)

cbdMD's Common Equity history spans 10 years, with the latest figure at $9.0 million for Q4 2025.

  • For Q4 2025, Common Equity rose 405.61% year-over-year to $9.0 million; the TTM value through Dec 2025 reached $9.0 million, up 405.61%, while the annual FY2025 figure was $7.2 million, 268.04% up from the prior year.
  • Common Equity for Q4 2025 was $9.0 million at cbdMD, up from $7.2 million in the prior quarter.
  • Across five years, Common Equity topped out at $103.1 million in Q3 2021 and bottomed at $665798.0 in Q1 2025.
  • The 5-year median for Common Equity is $17.4 million (2023), against an average of $32.4 million.
  • The largest annual shift saw Common Equity crashed 88.23% in 2024 before it soared 405.61% in 2025.
  • A 5-year view of Common Equity shows it stood at $84.4 million in 2021, then tumbled by 68.49% to $26.6 million in 2022, then crashed by 73.54% to $7.0 million in 2023, then crashed by 74.68% to $1.8 million in 2024, then skyrocketed by 405.61% to $9.0 million in 2025.
  • Per Business Quant, the three most recent readings for YCBD's Common Equity are $9.0 million (Q4 2025), $7.2 million (Q3 2025), and $6.1 million (Q2 2025).